| in Did You Know Facts
Pancreatic cancer has a genetic component.
According to Cleary, the KRAS gene, which causes about half of all human cancers, is mutated in more than 90% of cases of pancreatic cancer. However, a medication to turn off this specific gene has not yet been developed. One of oncology's "holy grails" is figuring out how to successfully target KRAS with a drug, according to Cleary. A Nobel Prize could be given to whoever develops an efficient KRAS targeted therapy because it is so crucial to oncology.
There are 176 universities worldwide that teach Hindi. 45 of these universities are from the United States.